Cargando…

Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Signature for Ovarian Cancers

Ovarian cancer (OC), one of the most common malignancies of the female reproductive system, is characterized by high incidence and poor prognosis. Tumor mutation burden (TMB), as an important biomarker that can represent the degree of tumor mutation, is emerging as a key indicator for predicting the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Mengjing, Xia, Qianqian, Zhang, Xing, Yan, Wenjing, Meng, Dan, Xie, Shuqian, Shen, Siyuan, Jin, Hua, Wang, Shizhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787320/ https://www.ncbi.nlm.nih.gov/pubmed/35087563 http://dx.doi.org/10.3389/fgene.2021.688207

Ejemplares similares

Esophageal Cancer Associated Immune Genes as Biomarkers for Predicting Outcome in Upper Gastrointestinal Tumors
por: Zhu, Chuanhui, et al.
Publicado: (2021)

Identification of autophagy-related risk signatures for the prognosis, diagnosis, and targeted therapy in cervical cancer
por: Meng, Dan, et al.
Publicado: (2021)

Fanconi Anemia Pathway Genes Advance Cervical Cancer via Immune Regulation and Cell Adhesion
por: Wang, Shizhi, et al.
Publicado: (2021)

Comprehensive analysis of prognosis-related alternative splicing events in ovarian cancer
por: Wang, Shizhi, et al.
Publicado: (2022)

Gene signature of m(6)A RNA regulators in diagnosis, prognosis, treatment, and immune microenvironment for cervical cancer
por: Wang, Shizhi, et al.
Publicado: (2022)

Immune-Related Genes’ Prognostic, Therapeutic and Diagnostic Value in Ovarian Cancer Immune-Related Gene Biomarker in Ovarian Cancer
por: Ding, Bo, et al.
Publicado: (2023)

Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)

Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
por: Huo, Xiao, et al.
Publicado: (2021)

Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer
por: Zhou, Zhangjian, et al.
Publicado: (2021)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
por: Sun, Hengzi, et al.
Publicado: (2019)

Identification and validation of ferroptosis-related lncRNA signatures as a novel prognostic model for glioma
por: Huang, Liang, et al.
Publicado: (2022)

A Novel Signature for Predicting Prognosis of Smoking-Related Squamous Cell Carcinoma
por: Chen, Chang, et al.
Publicado: (2021)

Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma
por: Yang, Wenlong, et al.
Publicado: (2022)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
por: Na, Zhijing, et al.
Publicado: (2021)

Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer
por: Wang, Bofang, et al.
Publicado: (2022)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma
por: Li, Ran, et al.
Publicado: (2020)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer
por: Li, Na, et al.
Publicado: (2021)

A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer
por: Pan, Xue, et al.
Publicado: (2021)

A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma
por: Fang, Xueying, et al.
Publicado: (2022)

Construction and validation of a histone acetylation-related lncRNA prognosis signature for ovarian cancer
por: Hu, Xiao-Qian, et al.
Publicado: (2022)

Construction and Validation of a Novel Glycometabolism-Related Gene Signature Predicting Survival in Patients With Ovarian Cancer
por: Liu, Lixiao, et al.
Publicado: (2020)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening
por: Chen, Min, et al.
Publicado: (2022)

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma
por: He, Yunan, et al.
Publicado: (2020)

Novel Model for Comprehensive Assessment of Robust Prognostic Gene Signature in Ovarian Cancer Across Different Independent Datasets
por: Bing, Zhitong, et al.
Publicado: (2019)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Development and Validation of a Three-Gene Prognostic Signature Based on Tumor Microenvironment for Gastric Cancer
por: Wang, Qian, et al.
Publicado: (2022)

Discovery and Validation of a Novel Metastasis-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Tang, Qiang, et al.
Publicado: (2022)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
por: Wang, Guangyao, et al.
Publicado: (2022)

Development and validation of a combined glycolysis and immune prognostic signature for lung squamous cell carcinoma
por: Huang, Qiang, et al.
Publicado: (2022)

Prognostic Model and Nomogram Construction and Validation With an Autophagy-Related Gene Signature in Low-Grade Gliomas
por: Li, Xinrui, et al.
Publicado: (2022)

Development of an Immune-Related Prognostic Signature in Breast Cancer
por: Xie, Peiling, et al.
Publicado: (2020)

Ferroptosis-Related Genes in Lung Adenocarcinoma: Prognostic Signature and Immune, Drug Resistance, Mutation Analysis
por: Ren, Ziyuan, et al.
Publicado: (2021)

Prognostic RNA-editing signature predicts immune functions and therapy responses in gliomas
por: He, Yi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9hltopcu62qddiuic6fcvfhriv